RE:Stiff fines may be coming to AMCoYeah I saw this as well while back. I believe the possible recourse is 10% of the annual earnings of the Company but its been a while since I did looked at this part. That puts the max exposure at somewhere near $60ish million USD.
jamesb14 wrote: I'm just a disgruntled former shareholder who occasionally looks back at Concordia to validate my decision. AMCo was the crown jewel of the Concordia organization, and with recent news of price gouging I just looked into it and found some of the price increases, like that of thyroid medication T3 unconscionable. The National Health Service has recourse however, and if I were a being man I'd say the day of reckoning is coming. My advice to the longs is to make sure you know what you're invested in and the potential risks if and when such fines are lodged against the company. Remember, Concordia is responsible for recourse even if this occurred under Cinven's watch. The link to the article is below. That is all. https://www.theguardian.com/business/2016/jun/04/jeremy-hunt-asks-competition-watchdog-to-look-at-drug-pricing